Cite Filings / HOWL / 0001346824-25-000040

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Werewolf Therapeutics, Inc. Filed 2025-11-06 Acc 0001346824-25-000040

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-11-17 SCHEDULE 13D/A Beneficial Ownership Report
2025-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2025-11-06 4 10% owner sold 242,890 shares at an average $1.22 ($295,781)
2025-11-06 4 10% owner sold 242,890 shares at an average $1.22 ($295,781)
2025-11-06 4 Director sold 155,885 shares at an average $1.22 ($189,830)
2025-11-04 144 Sale of Securities
2025-11-04 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…